http://orcid.org/0000-0002-9702-2999
Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sagar Dholariya, Deepak Parchwani, Siddhartha Dutta & Ragini Singh. (2023) Clinical efficacy and safety of dasiglucagon in severe hypoglycemia associated with patients of type 1 diabetes mellitus: a systematic review and meta-analysis. Expert Review of Clinical Pharmacology 16:1, pages 61-71.
Read now
Read now
Marjana Marinac, Jessie Sutphin, Campbell Hutton, Kathleen Klein, Sean Sullivan & Carol Mansfield. (2020) Preferences for Outcomes Among Adults with Type 1 Diabetes and Caregivers of Children with Type 1 Diabetes. Patient Preference and Adherence 14, pages 1719-1731.
Read now
Read now
Chioma Uzoigwe, Carol Mahler Hamersky, Deborah I Arbit, Wayne Weng & Michael S Radin. (2020) Assessing Prevalence of Hypoglycemia in a Medical Transcription Database. Diabetes, Metabolic Syndrome and Obesity 13, pages 2209-2216.
Read now
Read now
Articles from other publishers (28)
P. Lozeron, A. Boullet & S. Zeidan. (2024) Neuropatie delle ipoglicemie. EMC - Neurologia 24:2, pages 1-4.
Crossref
Crossref
Rishi GrahamLars MuellerMichelle ManningSteph HabifLaurel H. MesserJordan E. Pinsker & Eliah Aronoff-Spencer. (2024) Real-World Use of Control-IQ Technology Is Associated with a Lower Rate of Severe Hypoglycemia and Diabetic Ketoacidosis Than Historical Data: Results of the Control-IQ Observational (CLIO) Prospective Study. Diabetes Technology & Therapeutics 26:1, pages 24-32.
Crossref
Crossref
Carmen Yoldi Vergara, Ignacio Conget Donlo, Roque Cardona-Hernandez, Irune Goicoechea Manterola, María Teresa Rouco Gómez, Marina Llobet Garcés & Marta Ramon-Krauel. (2023) Psychometric analysis of the cross-cultural Spanish version of the diabetes management questionnaire. Journal of Pediatric Nursing 72, pages 146-152.
Crossref
Crossref
Bruno Guerci. (2023) Quelle place de la diabétologie connectée pour les patients en multi-injections d'insuline ?. Médecine des Maladies Métaboliques 17:2, pages 2S11-2S21.
Crossref
Crossref
Eric Renard, Camille Nevoret, Sophie Borot, Brigitte Delemer, Kamel Mohammedi, Ariane Sultan, Amar Bahloul, Amine Benkhelil, Bruno Detournay & Alfred Penfornis. (2023) Prise en charge du diabète de type 1 chez les adultes en France : l’étude SAGE. Médecine des Maladies Métaboliques 17:1, pages 81-87.
Crossref
Crossref
Yasaman Sharifi, Mahbube Ebrahimpur & Seyed Saeed Tamehrizadeh. (2022) Hypoglycemic unawareness: challenges, triggers, and recommendations in patients with hypoglycemic unawareness: a case report. Journal of Medical Case Reports 16:1.
Crossref
Crossref
Yaguang Zheng, Victoria Vaughan Dickson, Saul Blecker, Jason M Ng, Brynne Campbell Rice, Gail D’Eramo Melkus, Liat Shenkar, Marie Claire R Mortejo & Stephen B Johnson. (2022) Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review. JMIR Diabetes 7:2, pages e34681.
Crossref
Crossref
Kara Mizokami-Stout, Ryan Bailey, Lynn Ang, Grazia Aleppo, Carol J. Levy, Michael R. Rickels, Viral N. Shah, Sarit Polsky, Bryce Nelson, Anders L. Carlson, Francesco Vendrame & Rodica Pop-Busui. (2022) Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange. Journal of Diabetes and its Complications 36:5, pages 108148.
Crossref
Crossref
Jordan HinaharaStuart A WeinzimerEmilie R BromleyThomas F GossDavid M KendallMette Hammer. (2022) Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model. Journal of Managed Care & Specialty Pharmacy 28:4, pages 461-472.
Crossref
Crossref
Jerry R. FrankDeirdre BlissettRichard HellmundNaunihal Virdi. (2021) Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy. Diabetes Technology & Therapeutics 23:S3, pages S-36-S-44.
Crossref
Crossref
Lizheng Shi, Vivian Fonseca & Belinda Childs. (2021) Economic burden of diabetes-related hypoglycemia on patients, payors, and employers. Journal of Diabetes and its Complications 35:6, pages 107916.
Crossref
Crossref
Anders L. Carlson, Lauren G. Kanapka, Kellee M. Miller, Andrew J. Ahmann, Naomi S. Chaytor, Steven Fox, Lisa Kiblinger, Davida Kruger, Carol J. Levy, Anne L. Peters, Michael R. Rickels, Maamoun Salam, Viral N. Shah, Laura A. Young, Yogish C. Kudva & Richard Pratley. (2019) Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study. Journal of Diabetes Science and Technology 15:3, pages 582-592.
Crossref
Crossref
Noa Triki, Naama Yekutiel, Lilly Levi & Joseph Azuri. (2021) The effects of continuous glucose monitoring system on patient outcomes and associated costs in a real‐world setting. Diabetic Medicine 38:5.
Crossref
Crossref
Sanjay BajpaiSiew Wong-JacobsonDongju LiuBeth MitchellGinger HaynesKristen SyringAyad K AliChanadda Chinthammit. (2021) Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States. Journal of Managed Care & Specialty Pharmacy 27:3, pages 385-391.
Crossref
Crossref
Clifford J. Bailey & James R. GavinIIIIII. (2021) Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence. Clinical Diabetes 39:1, pages 64-71.
Crossref
Crossref
Sinu Bessy Abraham, Siddharth Arunachalam, Alex Zhong, Pratik Agrawal, Ohad Cohen & Chantal M. McMahon. (2019) Improved Real-World Glycemic Control With Continuous Glucose Monitoring System Predictive Alerts. Journal of Diabetes Science and Technology 15:1, pages 91-97.
Crossref
Crossref
João P. Ferreira, Francisco Araújo, Jorge Dores, Lèlita Santos, Estevão Pape, Mónica Reis, Árcia Chipepo, Edite Nascimento, Ana Baptista, Vanessa Pires, Carlos Marques, Adriana S. Lages, João Conceição, Pedro A. Laires, João Pelicano-Romano & Sílvia Alão. (2020) Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach. Diabetes Therapy 11:10, pages 2237-2255.
Crossref
Crossref
Weiwei Yu, Dongqi ZhouLi ZhangChen RumengPeishuai ZhangLisha Sun & Ziping Gao. (2020) Effect of sancai powder on glacemic variability of type 1 diabetes in China. Medicine 99:34, pages e20772.
Crossref
Crossref
Mei Hua Gao, Dimosthenis Giamouridis, N. Chin Lai, Tracy Guo, Bing Xia, Young Chul Kim, Viet Anh Nguyen Huu, Dorota Skowronska-Krawczyk, Louise Lantier, Raag Bhargava & H. Kirk Hammond. (2020) Urocortin 2 Gene Transfer Improves Glycemic Control and Reduces Retinopathy and Mortality in Murine Insulin Deficiency. Molecular Therapy - Methods & Clinical Development 17, pages 220-233.
Crossref
Crossref
Paulina Cruz. (2020) Inpatient Hypoglycemia: The Challenge Remains. Journal of Diabetes Science and Technology 14:3, pages 560-566.
Crossref
Crossref
Niloofar Khodabandehloo, Mitra Zarifkar, Delaram Eskandari, Nonasadat Ariashokooh, Amir Ziaee, Sahar Zandpoor & Alireza Hejrati. (2020) Evaluate the prevalence of depression in type 2 diabetics with microvascular complications. Journal of Family Medicine and Primary Care 9:6, pages 3060.
Crossref
Crossref
Q. Zhang, Y. Wu, Y. Lu & X. Fei. (2020) Eficacia y seguridad de la metformina y de los inhibidores del cotransportador-2 de sodio-glucosa en adultos con diabetes tipo 1: una revisión sistemática y metaanálisis en red. Revista Clínica Española 220:1, pages 8-21.
Crossref
Crossref
Sharon H. Saydah, Sundar S. Shrestha, Ping Zhang, Xilin Zhou & Giuseppina Imperatore. (2019) Medical Costs Among Youth Younger Than 20 Years of Age With and Without Diabetic Ketoacidosis at the Time of Diabetes Diagnosis. Diabetes Care 42:12, pages 2256-2261.
Crossref
Crossref
Jeremy H. Pettus, Fang Liz Zhou, Leah ShepherdRonald Preblick, Phillip R. Hunt, Sachin Paranjape, Kellee M. Miller & Steven V. Edelman. (2019) Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study. Diabetes Care 42:12, pages 2220-2227.
Crossref
Crossref
Carlos K. H. Wong, Thaison Tong, Garvin H. L. Cheng, Eric H. M. Tang, Praveen Thokala, Emily T. Y. Tse & Cindy L. K. Lam. (2019) Direct medical costs in the preceding, event and subsequent years of a first severe hypoglycaemia episode requiring hospitalization: A population‐based cohort study. Diabetes, Obesity and Metabolism 21:6, pages 1330-1339.
Crossref
Crossref
Sarah C Westen, Jennifer L Warnick, Anastasia Albanese-O’Neill, Desmond A Schatz, Michael J Haller, Mina Entessari & David M Janicke. (2019) Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy. Journal of Pediatric Psychology 44:1, pages 21-31.
Crossref
Crossref
Yingping Yi, Yawei Li, Anran Hou, Yanqiu Ge, Yuan Xu, Gang Xiong, Xinlei Yang, Stephanie Ann Acevedo, Lizheng Shi & Hua Xu. (2018) A Retrospective Cohort Study of Patients with Type 2 Diabetes in China: Associations of Hypoglycemia with Health Care Resource Utilization and Associated Costs. Diabetes Therapy 9:3, pages 1073-1082.
Crossref
Crossref
Kayleigh M. van Megen, Ernst-Jan T. van ’t Wout, Stephen J. Forman & Bart O. Roep. (2018) A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes. Frontiers in Immunology 9.
Crossref
Crossref